Aptose Biosciences (APS) Scheduled to Post Quarterly Earnings on Monday

Aptose Biosciences (TSE:APS – Get Rating) (NASDAQ:APTO) is scheduled to announce its earnings results after the market closes on Monday, May 8th. Analysts expect the company to announce earnings of C($0.16) per share for the quarter.

Aptose Biosciences Price Performance

Shares of APS stock opened at C$0.73 on Friday. The company has a debt-to-equity ratio of 3.45, a current ratio of 4.03 and a quick ratio of 5.41. The firm’s 50-day moving average is C$0.76 and its two-hundred day moving average is C$0.82. Aptose Biosciences has a 12 month low of C$0.60 and a 12 month high of C$1.53. The company has a market capitalization of C$67.90 million, a PE ratio of -1.06 and a beta of 1.73.

Get Aptose Biosciences alerts:

About Aptose Biosciences

(Get Rating)

Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.

See Also

• It’s Time To Check Into Booking.Com 
• Shopify Delivers Growth And Efficiency; Shares Surge 
• Advanced Micro Devices Bullish Reversal Is Still In Play
• Broadcom Shares Trade In Tight Range Ahead Of Q2 Earnings Report
• An Opportunity To Buy Starbucks Is Knocking On The Door 

Receive News & Ratings for Aptose Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptose Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.